{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"cocaine-embryofetopathy","columns":[{"gene":"","key":"population-ee9af14308a92233b3da","label":"Cocaine embryofetopathy","mondoId":"MONDO:0016007","onsetQualifier":null,"originColumnKey":"MONDO:0016007/ORPHA:1911","originalViews":[{"key":"MONDO:0016007/ORPHA:1911","label":"Cocaine embryofetopathy","scopeLabel":"ORPHA:1911","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["064f74f3766f1d040900b874baaef9fadb53ea41fc5d697d1f117da4205d3d10","4eb402b6df494ee3276caaeae8b9947943cff63f45d8657448061b238d74fb25","5fd0d8d867d7287bccefebde425a5e0642fecb7dac617a74993883ea19a1e029","78d082e6c2245d4959455d82ec4fc5eae02cbe6298108568de343781e1ad8abd","bd21efa4deea8776995dabce2d69265cc2a1361732c2b14a013b9f1285ea5015","c0b8c8b993ccf6dc8b07567c7ae22bf7e5fa7d0d14cb391af66d7695078017c6","d919b63ffc183969abc9f8e2a0c004bce0b3d7e15489b3904e637d8f48d9c68d","eb050e3dab25ede61928e3df829287e0f783138b98977653d1a4bc492169e68b"],"recordQualifiers":{},"scopeLabel":"ORPHA:1911","sourceIds":["ORPHA:1911"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-ee9af14308a92233b3da"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001626","HP:0000079","HP:0002084","HP:0001347","HP:0001276","HP:0011100","HP:0009882"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"orphanet":8}},"features":[{"hpoId":"HP:0001626","label":"Abnormality of the cardiovascular system","primary":true},{"hpoId":"HP:0000079","label":"Abnormality of the urinary system","primary":true},{"hpoId":"HP:0002084","label":"Encephalocele","primary":true},{"hpoId":"HP:0001347","label":"Hyperreflexia","primary":true},{"hpoId":"HP:0001276","label":"Hypertonia","primary":true},{"hpoId":"HP:0011100","label":"Intestinal atresia","primary":true},{"hpoId":"HP:0009882","label":"Short distal phalanx of finger","primary":true},{"hpoId":"HP:0100657","label":"Thoracoabdominal eventration","primary":false}],"ledeHtml":"A group of clinical signs observed in newborns exposed in utero to cocaine, a short-acting central nervous system stimulant used as a recreational drug through inhalation of the powder or intravenous injection. Cocaine use during pregnancy is associated with intrauterine growth restriction, low birth weight, seizures, respiratory distress (decreased apnea density and periodic breathing), feeding difficulties, irritability and lability of state, decreased behavioral and autonomic regulation, poor alertness and orientation and cognitive impairment (impaired auditory information processing , visual-spatial delay and subtle language delay) in the offspring.","mondoId":"MONDO:0016007","node":{"canonicalSlug":"cocaine-embryofetopathy","comparisons":[{"documentSha256":"9b9124fcba1af33faa7bdb446d1e3d97a06091a48cc044eb4e675372e5c36021","key":"legacy-cocaine-embryofetopathy","kind":"legacy","label":"cocaine embryofetopathy","memberIds":["MONDO:0016007"],"mondoId":"MONDO:0016007","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/cocaine-embryofetopathy.9b9124fcba1af33faa7bdb446d1e3d97a06091a48cc044eb4e675372e5c36021.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"cocaine embryofetopathy","paragraphs":["A group of clinical signs observed in newborns exposed in utero to cocaine, a short-acting central nervous system stimulant used as a recreational drug through inhalation of the powder or intravenous injection. Cocaine use during pregnancy is associated with intrauterine growth restriction, low birth weight, seizures, respiratory distress (decreased apnea density and periodic breathing), feeding difficulties, irritability and lability of state, decreased behavioral and autonomic regulation, poor alertness and orientation and cognitive impairment (impaired auditory information processing , visual-spatial delay and subtle language delay) in the offspring."],"scope":"exact","source":"MONDO","upstream":"Orphanet:1911","url":"https://monarchinitiative.org/MONDO:0016007"},"ownColumnKeys":["population-ee9af14308a92233b3da"],"publication":"published","relationships":[{"kind":"parent","label":"toxic or drug-related embryofetopathy","mondoId":"MONDO:0016677","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"064f74f3766f1d040900b874baaef9fadb53ea41fc5d697d1f117da4205d3d10","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:1911","disease_name":"Cocaine embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100657","is_excluded":false,"label":"Thoracoabdominal eventration","onset_id":null,"reference":"ORPHA:1911","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4eb402b6df494ee3276caaeae8b9947943cff63f45d8657448061b238d74fb25","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:1911","disease_name":"Cocaine embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000079","is_excluded":false,"label":"Abnormality of the urinary system","onset_id":null,"reference":"ORPHA:1911","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5fd0d8d867d7287bccefebde425a5e0642fecb7dac617a74993883ea19a1e029","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1911","disease_name":"Cocaine embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0009882","is_excluded":false,"label":"Short distal phalanx of finger","onset_id":null,"reference":"ORPHA:1911","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"78d082e6c2245d4959455d82ec4fc5eae02cbe6298108568de343781e1ad8abd","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1911","disease_name":"Cocaine embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002084","is_excluded":false,"label":"Encephalocele","onset_id":null,"reference":"ORPHA:1911","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bd21efa4deea8776995dabce2d69265cc2a1361732c2b14a013b9f1285ea5015","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:1911","disease_name":"Cocaine embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011100","is_excluded":false,"label":"Intestinal atresia","onset_id":null,"reference":"ORPHA:1911","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c0b8c8b993ccf6dc8b07567c7ae22bf7e5fa7d0d14cb391af66d7695078017c6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:1911","disease_name":"Cocaine embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001626","is_excluded":false,"label":"Abnormality of the cardiovascular system","onset_id":null,"reference":"ORPHA:1911","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d919b63ffc183969abc9f8e2a0c004bce0b3d7e15489b3904e637d8f48d9c68d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1911","disease_name":"Cocaine embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001276","is_excluded":false,"label":"Hypertonia","onset_id":null,"reference":"ORPHA:1911","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"eb050e3dab25ede61928e3df829287e0f783138b98977653d1a4bc492169e68b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1911","disease_name":"Cocaine embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"ORPHA:1911","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016007\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:1911</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A group of clinical signs observed in newborns exposed in utero to cocaine, a short-acting central nervous system stimulant used as a recreational drug through inhalation of the powder or intravenous injection. Cocaine use during pregnancy is associated with intrauterine growth restriction, low birth weight, seizures, respiratory distress (decreased apnea density and periodic breathing), feeding difficulties, irritability and lability of state, decreased behavioral and autonomic regulation, poor alertness and orientation and cognitive impairment (impaired auditory information processing , visual-spatial delay and subtle language delay) in the offspring.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016007\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"cocaine-embryofetopathy","sourceDocuments":[{"name":"MONDO: cocaine embryofetopathy","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0016007"}],"sourceNote":"","synonyms":["cocaine antenatal exposure","cocaine fetopathy","fetal cocaine syndrome","foetal cocaine syndrome","prenatal cocaine exposure"],"takeawayHtml":"","title":"cocaine embryofetopathy"},"schemaVersion":1}
